Panel discussion: breaking the link--clinical options to minimize risk

Aliment Pharmacol Ther. 1999 Mar:13 Suppl 1:19-23. doi: 10.1046/j.1365-2036.1999.00004.x.
No abstract available

MeSH terms

  • Cell Transformation, Neoplastic
  • Gastric Mucosa / microbiology
  • Gastric Mucosa / pathology
  • Helicobacter Infections / complications*
  • Helicobacter Infections / physiopathology
  • Helicobacter pylori / pathogenicity*
  • Humans
  • Risk Assessment
  • Stomach Neoplasms / etiology*
  • Stomach Neoplasms / microbiology
  • Stomach Neoplasms / physiopathology
  • Time Factors